Medtech Talk
Healthegy
Add to My Podcasts
Episodes
About
Reviews
Promote
Ceterix CEO John McCutcheon Is Writing a Different Ending with New Tech That Can Save the Meniscus
35 minutes
Posted Apr 26, 2018 at 4:00 am.
0:00
35:30
Add to My Queue
Download
MP3
Share
episode
Share at current time
Show notes
In 2010, John McCutcheon joined Ceterix, a start-up with big goals and a surer FDA path than his previous company. McCutcheon recounts the FDA's battering of that company, Emphasys, and explains how his current company is rolling today.
Previous
Intact CEO Bruce Shook Excited by New Round, Clinical Progress, and the Potential for Spin-off, Vesper
Next
NxThera CEO Bob Paulson Talks M&A, Career Twists, Family, and Lessons Learned from Selling Yogurt
← See all 206 episodes of Medtech Talk